Literature DB >> 7618155

Altered levels of urinary prostanoids in lead-exposed workers.

G Hotter1, L M Fels, D Closa, J Roselló, H Stolte, E Gelpí.   

Abstract

This paper describes the alteration of the urinary excretion of prostanoids in workers occupationally exposed to lead. For this purpose, the following groups were studied: Group 1 (n = 62): controls; Group 2 (n = 29): risk group; and Group 3 (n = 69): exposed group. Urine samples were collected for prostanoid analysis and lead blood levels were analyzed. Our results demonstrate that urinary excretion of prostanoids is already altered even at levels of lead in blood = 200 micrograms/l. Owing to their sensitivity, urinary prostanoids could be useful markers of early renal changes associated with lead exposure. However, underlying mechanisms should be elucidated and the health significance of such changes should be assessed before any conclusion is drawn.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7618155     DOI: 10.1016/0378-4274(95)03311-4

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

Review 1.  Mechanisms of lead-induced hypertension and cardiovascular disease.

Authors:  Nosratola D Vaziri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 2.  Lead-induced hypertension: role of oxidative stress.

Authors:  Nosratola D Vaziri; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 3.  Role of environmental toxicants in the development of hypertensive and cardiovascular diseases.

Authors:  Ehsan Habeeb; Saad Aldosari; Shakil A Saghir; Mariam Cheema; Tahani Momenah; Kazim Husain; Yadollah Omidi; Syed A A Rizvi; Muhammad Akram; Rais A Ansari
Journal:  Toxicol Rep       Date:  2022-03-22

4.  Ischemic heart disease risk factors in lead exposed workers: research study.

Authors:  Masoumeh Ghiasvand; Kamran Aghakhani; Ahmad Salimi; Ranjit Kumar
Journal:  J Occup Med Toxicol       Date:  2013-04-22       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.